Core Viewpoint - The company Infinitus (300582.SZ) has approved a capital increase and equity transfer agreement involving its wholly-owned subsidiary, aiming to invest in Qinghai Chunwarm Biotechnology Co., Ltd. and its existing shareholders [1][2] Group 1: Investment Details - Infinitus plans to invest a total of 13.44 million yuan in cash, which includes a capital increase of 1.344 million yuan and the remainder as capital premium [1] - The company will acquire all registered capital of 1.56 million yuan from Blincao Biotechnology Co., Ltd. for 1.56 million yuan [1] - After the transaction, Infinitus will hold 2.62% direct equity in the target company and an additional 3.04% indirectly through Blincao Biotechnology [1] Group 2: Profit Guarantees - The controlling shareholder and chairman, Guichaohua, has committed to a buyback agreement if the target company's net profit is negative for the years 2026 and 2027, or if the cumulative net profit for 2026, 2027, and 2028 does not reach 60 million yuan [2] - This transaction is classified as a related party transaction due to the buyback commitment [2]

Core Viewpoint - Infinitus (300582) announced an investment through its wholly-owned subsidiary, Hangzhou Infinitus Equity Investment Co., Ltd., to acquire stakes in Qinghai Spring Blossoms Biotechnology Co., Ltd. and Hangzhou Bincao Biotechnology Co., Ltd. [1] Group 1: Investment Details - The company plans to invest 13.44 million yuan in cash to subscribe for an additional registered capital of 1.344 million yuan in Qinghai Spring Blossoms, with the remaining amount recorded as capital surplus [1] - The company will also acquire all registered capital of 1.56 million yuan from Xu Danhong and Gao Minjian in Hangzhou Bincao Biotechnology Co., Ltd. [1] - After the transactions, the company will directly hold 2.62% of Qinghai Spring Blossoms and indirectly hold 3.04% through Bincao Biotechnology [1] Group 2: Technology and Business Focus - Qinghai Spring Blossoms utilizes biotechnology, plant growth lighting, and environmental control technology to standardize the supply of high-value-added raw materials [1] Group 3: Management Commitment - The company's actual controller and chairman, Guichao Hua, will assume a potential buyback obligation for this investment [1]

Core Viewpoint - Infinet (300582.SZ) has approved a capital increase and equity transfer agreement involving its wholly-owned subsidiary, Hangzhou Infinet Equity Investment Co., Ltd., and Qinghai Chunwarm Biotechnology Co., Ltd., indicating a strategic investment move in the biotechnology sector [1] Group 1: Investment Details - Infinet Equity Investment plans to invest CNY 13.44 million in Chunwarm Biotechnology, with CNY 1.344 million allocated to the new registered capital and the remainder as capital premium [1] - The company will also acquire all registered capital of Blincao Biotechnology for CNY 1.56 million, which is part of the overall transaction [1] - Upon completion of the transaction, Infinet Equity Investment will hold 2.62% direct equity in Chunwarm Biotechnology and an indirect 3.04% through Blincao Biotechnology [1] Group 2: Profit Guarantees - The controlling shareholder, GUICHAOHUA, has committed to a profit guarantee, allowing Infinet Equity Investment to demand a buyback of its shares if Chunwarm Biotechnology's net profit is negative over 2026 and 2027, or if the combined net profit for 2026, 2027, and 2028 does not reach CNY 60 million [2] - This transaction is classified as a related party transaction due to the involvement of the controlling shareholder [2]

证券代码：300582 证券简称：英飞特 公告编号：2025-067 英飞特电子（杭州）股份有限公司 关于对外投资及上市公司实控人对本次投资承担或有回购义务 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、交易概述 （一）对外投资基本情况 英飞特电子（杭州）股份有限公司（以下简称"英飞特"、"公司"、"上市公 司"）于2025年11月12日召开第四届董事会第十八次会议审议通过了《关于对外 投资及上市公司实控人对本次投资承担或有回购义务的议案》。 公司董事会同意公司全资子公司杭州英飞特股权投资有限公司（以下简称 "英飞特股权投资"、"杭州英飞特"或"投资人"）与青海春暖花开生物技术有限 公司（以下简称"春暖花开"或"标的公司"）及其现有股东浙江塞鼎新能源科技 有限公司（以下简称"塞鼎新能源"）、杭州博瑞昊华能源管理合伙企业（有限 合伙）（以下简称"博瑞昊华"）、杭州炎虫生物技术有限公司、杭州彬草生物 技术有限公司（以下简称"彬草生物"）、海东河湟实业（集团）有限公司（以 下简称"河湟实业"）和春暖花开的控股股东许丹红签署《增资认购协议》，并 与彬草生物及彬草 ...

证券代码：300582 证券简称：英飞特 公告编号：2025-068 英飞特电子（杭州）股份有限公司 关于召开 2025 年第二次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 1、股东会届次：2025 年第二次临时股东会 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交 易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号— 创业板上市公司规范运作》等法律、行政法规、部门规章、规范性文件及 《公司章程》的有关规定。 4、会议时间： （1）现场会议时间：2025 年 11 月 28 日 14:40 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间 为 2025 年 11 月 28 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易 所互联网投票系统投票的具体时间为 2025 年 11 月 28 日 9:15 至 15:00 的任意 时间。 5、会议的召开方式：现场表决与网络投票相结合。 6、会议的股权登记日 ...

英飞特电子（杭州）股份有限公司 第四届董事会第十八次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：300582 证券简称：英飞特 公告编号：2025-066 一、董事会会议召开情况 1、英飞特电子（杭州）股份有限公司（以下称"公司"或"上市公司"）第四 届董事会第十八次会议的会议通知于 2025 年 11 月 10 日通过邮件等方式送达至 各位董事，通知中包括会议的相关材料，同时列明了会议的召开时间、地点、 内容和方式。 2、本次董事会于 2025 年 11 月 12 日在公司会议室，以现场及通讯相结合 的方式召开。 3、本次董事会应出席董事 9 名，实际出席董事 9 名，其中现场出席会议的 董事 3 人，董事黄美兰、F MARSHALL MILES、应林光、竺素娥、孙笑侠、张 军明以通讯方式参加会议。 4、本次董事会由董事长 GUICHAO HUA 先生主持，公司高级管理人员列 席了本次董事会。 5、本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法 律法规和《公司章程》的有关规定。 二、董事会会议审议情况 会议审议并通 ...

Core Viewpoint - The company has approved several resolutions during its board meeting, including capital investments and acquisitions in the biotechnology sector [1] Group 1: Investment Activities - The company’s wholly-owned subsidiary, Yingfei Investment, will invest 13.44 million yuan to subscribe for an additional registered capital of 1.344 million yuan in Qinghai Chunwan Huakai Biotechnology Co., Ltd [1] - Yingfei Investment will acquire 100% of the registered capital of Bincao Biotechnology for 15.6 million yuan, resulting in a direct and indirect ownership of 5.66% in the target company [1] - The controlling shareholder and chairman, Guichaohua, will assume a contingent repurchase obligation for the investment [1] Group 2: Capital Increase - The company has agreed to increase the capital of Yingfei Investment by 25 million yuan, raising its registered capital to 52 million yuan [1] Group 3: Future Meetings - The company plans to hold its second extraordinary general meeting of shareholders on November 28, 2025 [1]

Core Insights - The optical and optoelectronic sector experienced a decline of 0.62% on November 12, with Infinet leading the drop [1] - The Shanghai Composite Index closed at 4000.14, down 0.07%, while the Shenzhen Component Index closed at 13240.62, down 0.36% [1] Stock Performance - Notable gainers in the optical and optoelectronic sector included: - He Guangxue (688127) with a closing price of 31.78, up 4.20% [1] - Su Da Weige (300331) at 32.35, up 2.80% [1] - Tengjing Technology (688195) at 122.20, up 2.17% [1] - Major decliners included: - Infinet (300582) with a closing price of 14.71, down 4.60% [2] - Changyang Technology (688299) at 18.56, down 3.58% [2] - Wavelength Optoelectronics (301421) at 98.18, down 3.16% [2] Capital Flow - The optical and optoelectronic sector saw a net outflow of 846 million yuan from institutional investors, while retail investors contributed a net inflow of 642 million yuan [2] - Specific stock capital flows included: - Wanrun Technology (002654) with a net inflow of 1.23 billion yuan from institutional investors [3] - Qianzhao Optoelectronics (300102) with a net inflow of 57.30 million yuan from institutional investors [3] - Su Da Weige (300331) with a net inflow of 33.54 million yuan from institutional investors [3]

证券代码：300582 证券简称：英飞特 公告编号：2025-065 英飞特电子（杭州）股份有限公司 关于控股股东、实际控制人减持股份实施进展暨权益变动触及 1%整数倍的公告 公司控股股东、实际控制人 GUICHAO HUA 先生保证向公司提供的信息内 容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 英飞特电子（杭州）股份有限公司（以下简称"公司"）于2025年9月22日披 露了《关于控股股东、实际控制人减持股份计划预披露的公告》（公告编号： 2025-059）。公司控股股东、实际控制人、董事长GUICHAO HUA先生计划在预 披露公告披露之日起15个交易日后的3个月内（2025年10月22日至2026年1月21 日）通过集中竞价、大宗交易方式减持公司股份不超过8,420,570 股（占公司总 股本的比例不超过2.82%，占剔除公司回购专用证券账户股份后总股本的比例不 超过2.89%）。 近日公司收到控股股东、实际控制人、董事长GUICHAO HUA先生出具的《关 于股份减持计划实施进展暨权益变动触及1%整数倍的告知函》。截至20 ...

Core Viewpoint - Infinet's stock price has shown a mixed performance in recent months, with a year-to-date increase of 11.51% and a notable rise of 7.26% over the last five trading days, despite a decline of 6.79% over the past 20 days [2]. Group 1: Stock Performance - As of November 6, Infinet's stock price increased by 2.22%, reaching 15.66 CNY per share, with a trading volume of 73.49 million CNY and a turnover rate of 2.17% [1]. - The company has a total market capitalization of 4.675 billion CNY [1]. - Year-to-date, Infinet's stock has risen by 11.51%, with a 7.26% increase in the last five trading days, a 6.79% decrease in the last 20 days, and a 10.28% increase over the last 60 days [2]. Group 2: Company Overview - Infinet Electronics (Hangzhou) Co., Ltd. was established on September 5, 2007, and went public on December 28, 2016. The company specializes in the research, production, sales, and technical services of LED driver power supplies [2]. - The revenue composition of Infinet is as follows: 94.62% from the LED lighting industry, 3.71% from other businesses, 1.19% from miscellaneous sources, and 0.48% from new energy-related products [2]. - Infinet is classified under the electronic industry, specifically in the optical optoelectronics-LED sector, and is associated with concepts such as plant lighting, OBC concept, LED, specialized and innovative enterprises, and new energy vehicles [2]. Group 3: Financial Performance - For the period from January to September 2025, Infinet reported a revenue of 1.737 billion CNY, reflecting a year-on-year decrease of 13.69%. The net profit attributable to the parent company was -78.77 million CNY, a significant decline of 269.15% year-on-year [2]. - As of September 30, 2025, Infinet had 22,700 shareholders, a decrease of 15.84% from the previous period, with an average of 9,774 circulating shares per person, an increase of 18.82% [2]. Group 4: Dividend and Shareholding - Since its A-share listing, Infinet has distributed a total of 128 million CNY in dividends, with 42.09 million CNY distributed over the past three years [3]. - As of September 30, 2025, the top ten circulating shareholders of Infinet saw the exit of the Dazheng Zhongzheng 360 Internet + Index A (002236) from the list [3].